Advertisement
Advertisement

HROW

HROW logo

Harrow, Inc. Common Stock

40.44
USD
Sponsored
+0.52
+1.30%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

40.45

+0.01
+0.01%

Harrow, Inc. Common Stock Profile

About

Harrow Inc. is an eyecare pharmaceutical company. It engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products principally for the U.S. market. Harrow Inc., formerly known as Harrow Health Inc., is based in NASHVILLE, Tenn.

Info & Links

CEO

Mark L. Baum

Headquarters

1A Burton Hills Blvd., Suite 200
Nashville, TN 37215, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.harrow.com

Auditor

Deloitte & Touche LLP

Share holders

56

Employees

373

Harrow, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.51B

Enterprise Value

1.71B

Enterprise Value/EBITDA(ttm)

39.25

Price to Earnings Ratio(ttm)

202.20

Price to Sales(ttm)

5.61

Price to Book(mrq)

53.17

Price to Cash(ytd)

46.79

Profitability

Gross Margin(ttm)

72.57%

Operating Margin(ttm)

3.21%

Profit Margin(ttm)

-11.44%

Return on Equity(ttm)

19.59%

Return on Invested Capital(ttm)

-0.33%

Return on Assets(ttm)

2.26%

Income Statement

Revenue(ttm)

268.68M

Revenue Per Share(ttm)

7.21

Gross Profit(ttm)

199.11M

EBITDA(ttm)3

43.44M

Net Income Available to Common(ttm)

-14.96M

Diluted EPS(ttm)

-0.41

Share Statistics

Beta (5Y Monthly)

0.28

52-Week Change

21.77%

S&P 500 52-Week Change

21.72%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

37.28M

Dividend Yield

0.00%

Float4

32.50M

% Held by Insiders

12.80%

% Held by Institutions

72.76%

Balance Sheet

Total Cash(mrq)

94.64M

Total Cash Per Share(mrq)

2.54

Total Debt(mrq)

292.09M

Total Debt/Equity(mrq)

1030.25%

Current Ratio(mrq)

2.48%

Quick Ratio(mrq)

2.30%

Book Value Per Share(mrq)

0.76

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.24

Free Cash Flow(ytd)

-9.19M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement